OKYO Pharma Ltd is a biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
OKYO is expected to report earnings to fall 33.33% to -1 cents per share on September 02
Q2'26
Est.
$-0.02
Q1'26
Beat
by $0.05
Q4'25
Est.
$-0.05
Q3'25
Beat
by $0.02
Q2'25
Beat
by $0.02
The last earnings report on June 03 showed earnings per share of -2 cents, beating the estimate of -7 cents. With 146.34K shares outstanding, the current market capitalization sits at 81.61M.